Our Investment Strategy
BioScience Managers is highly selective and looks carefully for value creating investment opportunities with clear technological and market advantages where we can have an opportunity to influence commercial success.
We are both geographically and therapeutically agnostic. We invest in public and private healthcare companies in any territory which work in therapeutics, medical devices, diagnostics or digital health, which are in or near clinical development or commercialisation. In addition, the companies should have effective management teams.
Our strategy is to take a a meaningful stake in our investee companies that adds significantly more value than just “capital invested”. This involves board representation as well as advisory and or hands-on-roles to augment existing skills and to build a proactive and supportive relationships.
We have a long term view to investing with a commitment to supporting our investee companies through change and growth to a level where they have achieved a significant increase in value.
Our aim is to then divest either through a trade sale or via the stock market, once a portfolio company has achieved commercial success.